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Background: Fracture of the femur is themost frequent late complication in patientswith soft
tissue sarcomas (STS) who receive external beam radiotherapy after limb-sparing surgery.
Aim: To reduce the risk of bone fracture following radiotherapy of STS of the thigh, we
minimized the dose to the femur and to surrounding normal tissues by applying intensity
modulated radiation therapy (IMRT). We report preliminary results of post-surgery IMRT of
the thigh in patients with STS in this extremity.
Materials and methods: 10 adult patients undergoing post-operative radiotherapy of STS of
the thigh were treated using IMRT. Clinical IMRT plans with simultaneous integrated boost
(SIB) and 3-phase three-dimensional conformal radiotherapy (3D-CRT) were designed to
adequately treat the planning target volume and to spare the femur to the largest extent
possible. Dose distributions and dose-volume histograms were compared.
Results: For either technique, a comparable target coverage was achieved; however, target
volume was better covered and critical structures were better spared in IMRT plans. Mean
and maximum doses to OAR structures were also signiﬁcantly reduced in the IMRT plans.
On average, the mean dose to the femur in 3D-CRT plans was about two times higher thanthat in IMRT plans.
Conclusion: Compared with 3D-CRT, the application of IMRT improves the dose distribu-
tion within the concave target volumes and reduces dose to the OAR structures without
compromising target coverage.
land
neoplasms in adults or children, respectively. The incidence of© 2011 Greater Po
1. BackgroundSoft tissue sarcomas (STS) are rare neoplasms originating
from mesenchymal tissue. Histologically, they form a het-
∗ Corresponding author.
E-mail address: z5sladow@cyf-kr.edu.pl (A. S´ladowska).
1507-1367/$ – see front matter © 2011 Greater Poland Cancer Centre, Poland
doi:10.1016/j.rpor.2011.02.006Cancer Centre, Poland. Published by Elsevier Urban & Partner Sp.
z.o.o. All rights reserved.
erogeneous group. STS occur in about 1% and 10% of allSTS in Poland (population of ca. 40 million) is about 800–1000
new cases and is increasing.1 STS occur most frequently
in the extremities (60%). Surgery (limb sparing surgery) is
. Published by Elsevier Urban & Partner Sp. z.o.o. All rights reserved.
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dreports of practical oncology and
he treatment of choice; nevertheless, radiotherapy is impor-
ant in adjuvant and neoadjuvant approaches.2 A combined
urgery and radiotherapy improve the patient’s quality of
ife and achieve local control rates equivalent to those after
mputation.2–5
Irradiation of STS may signiﬁcantly elevate the risk of mor-
idity, including wound and skin complications, contractures,
edema, or bone fracture and may introduce region-speciﬁc
omplications (genital in the case of thigh, or spinal cord and
alivary gland in the case of head andneck sarcomas).6 Wound
omplications may be related to the sequence and timing of
urgery and irradiation.3
The risk due to radiotherapy may be further reduced by
sing appropriate radiotherapy techniques. It is essential to
pare the circumference of the irradiated extremity and to
void irradiating adjacent areas, such as the contralateral
high or the genital region. The relative risk of bone fracture
fter radiotherapy (5%) is lower than that of other com-
lications, but it can exceed 25% if periosteal stripping is
erformed.7 Because treatment of such fractures is difﬁcult
nd prolonged, and causes a decrease in the patient’s quality
f life, dose to the bone should be minimized.8
Because the target volume is large and irregular and lies
lose to bone structures, 3D-CRT treatment plans become
uite complicated and are not always satisfactory. The shape
f the lesion around the surrounding bone after complete
urgical excision is usually quite irregular. It is therefore tech-
ically difﬁcult to treat such a volume homogeneously, while
paring the bone cortex of the adjacent bone. A conventional
D treatment plan employs ﬁelds covering the entire target
ith large margins and minimal sparing of normal tissue. The
pplication of the IMRT technique permits high doses of radi-
tion to be delivered much more precisely than in the case of
onventional radiotherapy.9
. Aim
e explored the possibility of clinically applying IMRT to treat
oft tissue sarcoma of the thigh to demonstrate its advan-
age versus conventional 3D-CRT treatment of this site, in
erms of dose distribution, target coverage and normal tissue
paring.
. Materials and methods
adiotherapy plans for 10 patients with STS of the thigh
ere examined and compared. All patients underwent limb-
paring surgery. The patients were immobilized as close as
ossible to their neutral anatomic position. To minimize
atient movement, customized foam moulded under their leg
nd a thermoplasticmask ﬁxed onto the baseboardwere used.
he surgical scar was marked using CT-compatible wire to
elineate the anatomic boundaries of the tumour or scar and a
olus was placed to move the build-up zone closer to the skin
urface. 2.5-mm slice CT scans were acquired and transferred
o a Varian-Eclipse planning system (Varian Medical Systems,
nc.). Appropriate planning target volumes (PTVs) based onCT,
s well as normal tissue and organs at risk structures, were
elineated. The tumour bed was deﬁned using pre-operativetherapy 1 6 ( 2 0 1 1 ) 110–114 111
imaging and surgical clips. The surgical scar was marked over
the skin surface. PTV1 consisted of the tumour bedwith a 2 cm
margin in all directions. PTV2 was formed by adding a 3 cm
margin axially to the tumour bed and 5–7 cm superior/inferior
margins. PTV3 included PTV1, PTV2 and the whole muscular
compartment. PTV was modiﬁed to exclude the bone and a
0.5 cm layer beneath the skin surface. In all patients, the entire
femur was contoured as a critical structure and normal tissue
was deﬁned as the limb, excluding the PTV1 and the femur.
The same target volumes of OAR and of normal tissues were
used to prepare 3D-CRT and IMRT plans.
For every patient, 3D-CRT plans were developed using
3–4 beams. Targets were treated sequentially and required
separate dose plans with different dose prescriptions. The
three-phase technique using shrinking ﬁelds was employed.
The prescribed doses were ﬁrst to deliver 50Gy in 25 fractions
to PTV3, next 10Gy in 5 fractions to PTV2, and ﬁnally 10Gy in
5 fractions to PTV1.
IMRT plans employing 7–8 ﬁelds were generated using the
simultaneous integrated boost (SIB) technique where all tar-
gets are treated within a single treatment plan over the entire
treatment course.10 The linear quadratic concept was applied
and doses were re-calculated in terms of biologically equiv-
alent dose (BED) in order to provide equivalent doses in the
comparison.11,12
Patients were treated with 6MV photons generated by
a Varian 2300 C/D accelerator equipped with a Millennium
120-leaf MLC (both from Varian Medical Systems, Inc.). IMRT
plans were generated using ECLIPSE/HELIOS software (Varian
Medical Systems, Inc.) which includes an inverse planning
algorithm. The sliding windows technique13 was used for
delivery. In both techniques, the gantry angles were chosen
in such a way as to avoid irradiation of the contralateral leg.
In two of the ten patients treated, ﬁelds of lengths exceed-
ing 40 cm were required, thus two separate isocenters had to
be introduced. For these two patients, we developed a two-
isocenter system, for IMRT and for the initial phases of the
3D-CRT technique.
The 3D and the IMRT plans were generated and dose dis-
tributions were ﬁrst compared visually over axial, sagital and
coronal slices with respect to the degree of target conformity
within the prescribed dose to the PTVS. Plans were evaluated
by comparing dose volume histograms (DVHs) for planning
target volumes and organ-at-risk structures.
Theminimumdose (Dmin) and themaximumdose (Dmax) to
the PTVswere evaluated. The optimization goalwas to achieve
95–105% of the prescribed dose to PTV1, PTV2 and PTV3. Tar-
get coverage was estimated by comparing the percentage of
PTV3 receiving at least 95% of dose (V95%). The mean and the
maximumdose (Dmean andDmax, respectively) and the volume
of the femur receiving 45Gy (V45) or more were studied. This
dose-volume constraint was chosen because fracture of the
femur is more frequent in patients receiving high-dose radio-
therapy (60–66Gy) than in those receiving 50Gy or less (10%
vs. 2%).14
A dose to the femur was assessed high if encompassing
5% of the volume (D5). The dose parameters concerning PTVs
and the femur were summarized in the form of mean (includ-
ing±SD errors) and median values calculated over all patient
treatment plans.
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ientFig. 1 – Example of transversal isodose distribution for a pat
3D-CRT and (B) IMRT techniques.
4. ResultsFor each patient, the 3D and the IMRT plans met physician-
speciﬁed clinical criteria concerning target dose and bone
sparing. A typical dose distribution for the 3D-CRT and IMRT
plans is shown in Fig. 1. Target coverage, as measured by
Fig. 2 – Comparison of dose-volume histograms (DVH) for the pa
and PTV3 volumes for 3D-CRT and IMRT techniques used in treawith soft tissue sarcoma of the thigh treated with: (A)
the V95 volume, was comparable, the average for PTV3 being
98.1±1.4% (3D-CRT) and 98.5±1.2% (IMRT). The 3D-CRT and
IMRT plans showed no signiﬁcant differences in the PTV
regions, with the exception of the average value of Dmax,
which was lower in the case of IMRT (104.7±2.1%) than
that for 3D-CRT (107.3±1.3%). The adjustment of dose dis-
tribution to the target volumes and conformity within given
tient of Fig. 1: (a) cumulative (b) differential in PTV1, PTV2
tment of this patient.
reports of practical oncology and radio
Table 1 – Dose parameters (Gy) concerning the femur in
10 patients with STS of the thigh treated with 3D-CRT
and IMRT techniques: mean (including ±1SD errors) and
median values, calculated for all treatment plans of
these patients.
Femur 3D-CRT IMRT
Dmean [Gy] 28.1–37.2 19.6–33.8
Mean (±1SD) 32.4 (±3.1) 22.2 (±2.2)
Median 30.9 22.2
Dmax [Gy] 65.1–74 60.4–68.3
Mean (±1SD) 70.6 (±3.1) 64.9 (±2.3)
Median 71.6 64.9
D5 [Gy] 57.3–70.2 42.9–60.1
Mean (±1SD) 64.04 (±4.4) 53.2 (±4.0)
Median 65.65 54.1
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IMRT plans achieved more precisely the prescription doseV45 [%] 37.5–48.6 16–25.5
Mean (±1SD) 41.13 (±3.2) 21.48 (±4.6)
Median 44.62 20.8
lanning target volumes (PTV1, PTV2, or PTV3) were bet-
er in the IMRT plans. This is also seen in the comparison
f dose-volume histograms shown in Fig. 2, where bet-
er conformity of the IMRT plan over the target volume is
vident.
Signiﬁcant reduction in the dose to the femur and to sur-
ounding normal tissue was achieved by the IMRT technique.
he maximum dose to the bone, which is one of the clini-
al criteria, was reduced from 70.6±3.1Gy in the conformal
lans to 64.9±2.3Gy in the IMRT plans. Also the high dose
egions (D5) decreased by an average of 16% from64.04±4.4Gy
n 3D-CRT to 53.2±4.0Gy in the IMRT technique. Although,
n the low-dose region, the IMRT plans extended over larger
olumes than those for conformal plans, the IMRT technique
ave a 31.48% decrease of the average dose to the femur, Dmean
from 32.4±3.1Gy for 3D CRT to 22.2±2.2Gy for IMRT). Fur-
hermore, IMRT delivery led to a signiﬁcantly lower volume of
emur receiving 45Gy (V45) or more. The mean V45 volume in
D-CRT planswas higher by a factor of almost two than that in
MRT plans (Table 1). The IMRT plans targeted more precisely
he prescription dose around the PTVs also reducing hot and
old spots within the target volumes. Due to the larger mar-
ins used in the 3D-technique, the irradiated volumes were
reater than the target volumes causing higher doses to be
elivered to higher volumes of healthy tissues.
. Discussion
n this study,wedemonstrated the superiority of IMRTby com-
arative evaluation of clinically acceptable 3D-CRT and IMRT
lans prepared in our Centre of Oncology to treat patientswith
oft tissue sarcoma of the thigh. Treatment plans using 3D-
RT and IMRT techniqueswere evaluated and compared for 10
atients undergoing post-operative radiotherapy for extrem-
ty STS. Dose distributions and dose–volume histograms were
nalyzed.The comparison of dose distributions revealed that while
TV coverage was comparable between IMRT and 3D-CRT
echniques, IMRT treatment plans showed better dose con-
ormity with the target volumes, especially where concavetherapy 1 6 ( 2 0 1 1 ) 110–114 113
dose distributions were required. Signiﬁcant reductions in the
mean and the maximum doses to the femur in all patients
were also achieved. The volume of the femur receiving at least
45Gy (V45) decreased on average by approximately 50% and
hot spots (D5) were reduced on average by 16%. Reduction of
high-dose delivered to the femur resulted in minimizing the
risk of bone fracture, a possible late complication of radiation
treatment.
The results we obtained agree well both in terms of target
coverage and sparing of bone structures with other simi-
lar investigations.15,16 Radiotherapy of STS of the thigh can
either be accomplished using 3D-CRT or by IMRT techniques.
However, some authors have suggested the use of the IMRT
technique to reduce the mean dose to the femur without
compromising target coverage.6,9 Alektiar et al.9 performed
treatment planning for 41 patients with limb sparing surgery
and adjuvant IMRT, achieving better sparing of normal tissue
and improved local control in treating STS of the extremity.
Koshy et al.17 compared IMRT with 3D-CRT techniques in 15
patients with retroperitoneal sarcoma. Application of IMRT
allowed them to improve target coverage and to better spare
critical structures: small bowel, liver and kidney. Also, IMRT
was well tolerated and acute toxicity decreased.
Due to the variations in their shape and to large and often
concave target volumes, conformal dose distribution can sel-
dom be successfully achieved with 3D-CRT techniques. Using
the multiple isocenter technique, IMRT can be used not only
for small, but also for large tumour volumes, even those
exceeding 40 cm in length.
By using simultaneous integrated boost radiotherapy (SIB),
multiple target volumes receiving different prescribed doses
can be integrated into a single treatment plan. Additionally,
the SIB technique offers the possibility of reducing the number
of fractions required, thus reducing the complexity and timeof
treatment delivery. In our Centre, we have observed that IMRT
with simultaneous integrated boost is equivalent in terms of
dose delivery and more proﬁtable than three-phase 3D-CRT.
Because of the risk of potential complications from a small
volume receiving a high dose as compared to that of large vol-
ume receiving low dose, the accuracy of patient positioning
and immobilization may crucially affect the outcome of IMRT.
Therefore, this treatment should be closely observed and con-
trolled through stringent Quality Assurance procedures.
6. Conclusion
The application of IMRT in soft tissue sarcoma of the thigh
offers signiﬁcant beneﬁts with respect to 3D-CRT. IMRT in the
treatment of soft tissue sarcoma of the thigh enabled us to
improve target dose conformity and to signiﬁcantly reduce
dose to the surrounding normal tissues and bone structure,
compared with conventional 3D-CRT planning. Furthermore,around the target. Longer follow-up is required to determine
whether possible late complications of radiation treatment are
indeed reduced by the application of IMRT to treat soft tissue
sarcomas located in the thigh region.
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